Literature DB >> 26492630

Risk factor analysis of cerebral white matter hyperintensities in children with sickle cell disease.

Veronica van der Land1, Henri J M M Mutsaerts2, Marc Engelen3, Harriët Heijboer1, Mark Roest4, Martine J Hollestelle5, Taco W Kuijpers1, Paul J Nederkoorn6, Marjon H Cnossen7, Charles B L M Majoie2, Aart J Nederveen2, Karin Fijnvandraat1.   

Abstract

Sickle cell disease (SCD) is complicated by silent cerebral infarcts, visible as white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI). Both local vaso-occlusion, elicited by endothelial dysfunction, and insufficiency of cerebral blood flow (CBF) have been proposed to be involved in the aetiology. We performed an explorative study to investigate the associations between WMHs and markers of endothelial dysfunction and CBF by quantifying WMH volume on 3.0 Tesla MRI. We included 40 children with HbSS or HbSβ(0) thalassaemia, with a mean age of 12.1 ± 2.6 years. Boys demonstrated an increased risk for WMHs (odds ratio 4.5, 95% confidence interval 1.2-17.4), unrelated to glucose-6-phosphate dehydrogenase deficiency. In patients with WMHs, lower fetal haemoglobin (HbF) was associated with a larger WMH volume (regression coefficient = -0.62, R2 = 0.5, P = 0.04). Lower ADAMTS13 (a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13) levels were associated with lower CBF in the white matter (regression coefficient = 0.07, R2 = 0.15, P = 0.03), suggesting that endothelial dysfunction could potentially hamper CBF. The findings of our explorative study suggest that a high level of HbF may be protective for WMHs and that endothelial dysfunction may contribute to the development of WMHs by reducing CBF.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  cerebral blood flow; sickle cell disease; white matter hyperintensities

Mesh:

Substances:

Year:  2015        PMID: 26492630     DOI: 10.1111/bjh.13819

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

Review 1.  New insights into sickle cell disease: mechanisms and investigational therapies.

Authors:  Gregory J Kato
Journal:  Curr Opin Hematol       Date:  2016-05       Impact factor: 3.284

2.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2016-10

Review 3.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Patricia M Fortin; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2017-05-13

Review 4.  Fetal hemoglobin in sickle cell anemia.

Authors:  Martin H Steinberg
Journal:  Blood       Date:  2020-11-19       Impact factor: 22.113

5.  Disease severity and slower psychomotor speed in adults with sickle cell disease.

Authors:  Dana R Jorgensen; Andrea Metti; Meryl A Butters; Joseph M Mettenburg; Caterina Rosano; Enrico M Novelli
Journal:  Blood Adv       Date:  2017-09-14

Review 6.  Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease.

Authors:  Anna M Hood; Lori E Crosby; Hanne Stotesbury; Melanie Kölbel; Fenella J Kirkham
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

7.  Determinants of resting cerebral blood flow in sickle cell disease.

Authors:  Adam M Bush; Matthew T Borzage; Soyoung Choi; Lena Václavů; Benita Tamrazi; Aart J Nederveen; Thomas D Coates; John C Wood
Journal:  Am J Hematol       Date:  2016-07-04       Impact factor: 10.047

Review 8.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

9.  Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease.

Authors:  Julie Coloigner; Ronald Phlypo; Thomas D Coates; Natasha Lepore; John C Wood
Journal:  Brain Connect       Date:  2017-09

10.  Interventions for preventing silent cerebral infarcts in people with sickle cell disease.

Authors:  Lise J Estcourt; Catherine Kimber; Sally Hopewell; Marialena Trivella; Carolyn Doree; Miguel R Abboud
Journal:  Cochrane Database Syst Rev       Date:  2020-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.